120 related articles for article (PubMed ID: 8179342)
21. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
22. Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
Paquet P; De Groote D; Piérard GE
Dermatology; 2010; 220(3):201-7. PubMed ID: 20332596
[TBL] [Abstract][Full Text] [Related]
23. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).
Paquet P; Piérard GE; Quatresooz P
Int Arch Allergy Immunol; 2005 Mar; 136(3):205-16. PubMed ID: 15713983
[TBL] [Abstract][Full Text] [Related]
24. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
Paquet P; Ribbens C; Piérard GE
Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
[TBL] [Abstract][Full Text] [Related]
25. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
[TBL] [Abstract][Full Text] [Related]
26. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
[TBL] [Abstract][Full Text] [Related]
27. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
[TBL] [Abstract][Full Text] [Related]
28. [Toxic epidermal necrolysis].
Carrillo-Esper R; Elizondo-Argueta S; Sánchez-Zúñiga Mde J; Visoso-Palacios P; Cedillo-Torres H; Carrillo-Córdova JR
Gac Med Mex; 2006; 142(4):337-40. PubMed ID: 17022310
[TBL] [Abstract][Full Text] [Related]
29. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A
Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327
[No Abstract] [Full Text] [Related]
30. Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis.
Paquet P; Jacob E; Quatresooz P; Jacquemin D; Piérard GE
Burns; 2007 Feb; 33(1):100-4. PubMed ID: 17079086
[TBL] [Abstract][Full Text] [Related]
31. Erythema multiforme and toxic epidermal necrolysis: a comparative study.
Paquet P; Piérard GE
Am J Dermatopathol; 1997 Apr; 19(2):127-32. PubMed ID: 9129696
[TBL] [Abstract][Full Text] [Related]
32. Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review).
Paquet P; Pierard GE
Int J Mol Med; 2007 Jan; 19(1):3-10. PubMed ID: 17143541
[TBL] [Abstract][Full Text] [Related]
33. [Lyell syndrome in Senegal: responsibility of thiacetazone].
Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
[TBL] [Abstract][Full Text] [Related]
34. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis.
Szyllo K; Tchorzewski H; Banasik M; Glowacka E; Lewkowicz P; Kamer-Bartosinska A
Mediators Inflamm; 2003 Jun; 12(3):131-8. PubMed ID: 12857596
[TBL] [Abstract][Full Text] [Related]
35. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.
Mansur AT; Aydingöz IA
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):100-2. PubMed ID: 15752129
[TBL] [Abstract][Full Text] [Related]
36. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
37. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
38. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.
Persson J; Nilsson J; Lindholm MW
Lipids Health Dis; 2006 Jun; 5():17. PubMed ID: 16800873
[TBL] [Abstract][Full Text] [Related]
39. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin.
Farrell AM; Marren P; Dean D; Wojnarowska F
Br J Dermatol; 1999 Jun; 140(6):1087-92. PubMed ID: 10354075
[TBL] [Abstract][Full Text] [Related]
40. Synovial hyperplasia in HTLV-I associated arthropathy is induced by tumor necrosis factor-alpha produced by HTLV-I infected CD68+ cells.
Yin W; Hasunuma T; Kobata T; Sumida T; Nishioka K
J Rheumatol; 2000 Apr; 27(4):874-81. PubMed ID: 10782809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
